Oxford Drug Design Limited

Oxford Drug Design Limited is an SME in London, United Kingdom that has taken part in 3 EU-funded projects since 2009, receiving €1.6M in EU funding.

EU funding received€1.6M
EU projects3
As coordinator0
Running now0
First EU project2009
Latest project2018
CountryUnited Kingdom
EU registration (PIC)996077966
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Oxford Drug Design Limited's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.4M · 2 projects
  • Horizon 2020€273k · 1 project

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • CARTNETPartner

    Combatting Antimicrobial Resistance Training Network

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €273ktheir share
  • NABARSIPartner

    New AntiBacterials with Inhibitory activity on Aminoacyl-tRNA Synthetases

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €1.0Mtheir share
  • STARSPartner

    Scientific Training in Antimicrobial Research Strategies

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €334ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • bacteriology
  • cell biology
  • drug discovery
  • enzymes
  • genetic engineering
  • medicinal chemistry
  • multidrug resistance
  • structural biology
  • veterinary sciences

Oxford Drug Design Limited is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime